The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma

Objectives. Chemotherapy as first-/second-line treatment in different epidermal growth factor receptor (EGFR) mutation lung adenocarcinoma remains controversial. Methods. Consecutive patients were collected between 2009 and 2012. Patients were divided into two groups (1st-line chemotherapy: n = 56 a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Chung, Fu-Tsai, Ho, Ming-Yun, Fang, Yueh-Fu, Hshieh, Meng-Heng, Wang, Tsai-Yu, Kuo, Chih-Hsi, Chen, Hao-Cheng, Wang, Chun-Hwa, Lin, Shu-Min, Yu, Chih-Teng, Lin, Horng-Chyuan, Kuo, Han-Pin
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4644829/
https://ncbi.nlm.nih.gov/pubmed/26609535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/948267
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы